Cytophage Technologies (TSXV:CYTO) Price-to-Tangible-Book : 4.46 (As of May. 29, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Price-to-Tangible-Book?

As of today (2024-05-29), Cytophage Technologies's share price is C$0.45. Cytophage Technologies's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was C$0.10. Hence, Cytophage Technologies's Price to Tangible Book Ratio of today is 4.46.

The historical rank and industry rank for Cytophage Technologies's Price-to-Tangible-Book or its related term are showing as below:

TSXV:CYTO' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0 Med: 0 Max: 4.8
Current: 4.5

During the past 3 years, Cytophage Technologies's highest Price to Tangible Book Ratio was 4.80. The lowest was 0.00. And the median was 0.00.

TSXV:CYTO's Price-to-Tangible-Book is ranked worse than
69.12% of 1221 companies
in the Biotechnology industry
Industry Median: 2.79 vs TSXV:CYTO: 4.50

A closely related ratio is called PB Ratio. As of today, Cytophage Technologies's share price is C$0.45. Cytophage Technologies's Book Value per Sharefor the quarter that ended in Dec. 2023 was C$0.10. Hence, Cytophage Technologies's P/B Ratio of today is 4.46.

Cytophage Technologies Price-to-Tangible-Book Historical Data

The historical data trend for Cytophage Technologies's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Price-to-Tangible-Book Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Sep23	Dec23
Price-to-Tangible-Book	-	-	-	-	-

Competitive Comparison of Cytophage Technologies's Price-to-Tangible-Book

For the Biotechnology subindustry, Cytophage Technologies's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cytophage Technologies's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytophage Technologies's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cytophage Technologies's Price-to-Tangible-Book falls into.

Cytophage Technologies Price-to-Tangible-Book Calculation

Cytophage Technologies's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.45	/	0.101
	=	4.46

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Cytophage Technologies Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.